Avidity Biosciences (RNA) Accumulated Depreciation & Amortization (2019 - 2025)
Historic Accumulated Depreciation & Amortization for Avidity Biosciences (RNA) over the last 7 years, with Q3 2025 value amounting to $10.4 million.
- Avidity Biosciences' Accumulated Depreciation & Amortization rose 4391.79% to $10.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.4 million, marking a year-over-year increase of 4391.79%. This contributed to the annual value of $8.0 million for FY2024, which is 5316.99% up from last year.
- Avidity Biosciences' Accumulated Depreciation & Amortization amounted to $10.4 million in Q3 2025, which was up 4391.79% from $9.6 million recorded in Q2 2025.
- Over the past 5 years, Avidity Biosciences' Accumulated Depreciation & Amortization peaked at $10.4 million during Q3 2025, and registered a low of $1.7 million during Q1 2021.
- Over the past 5 years, Avidity Biosciences' median Accumulated Depreciation & Amortization value was $4.0 million (recorded in 2023), while the average stood at $4.8 million.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first crashed by 1243.05% in 2021, then skyrocketed by 8003.46% in 2022.
- Quarter analysis of 5 years shows Avidity Biosciences' Accumulated Depreciation & Amortization stood at $1.7 million in 2021, then surged by 80.03% to $3.1 million in 2022, then surged by 67.34% to $5.2 million in 2023, then soared by 53.17% to $8.0 million in 2024, then skyrocketed by 30.64% to $10.4 million in 2025.
- Its Accumulated Depreciation & Amortization was $10.4 million in Q3 2025, compared to $9.6 million in Q2 2025 and $8.8 million in Q1 2025.